(S) - (-) -MRJF22
(S) - (-) -MRJF22 is haloperidol metabolite II valproate ester. (S) - (-) -MRJF22 exhibits the high antimigratory effects in endothelial and tumor cells. (S) - (-) -MRJF22 is a potential multifunctional agent against uveal melanoma[1].
Product Specifications
CAS Number
2757301-90-7
UNSPSC
12352005
Target
Drug Metabolite
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/s-minus-mrjf22.html
Solubility
10 mM in DMSO
Smiles
CCCC(C(O[C@H](C1=CC=C(C=C1)F)CCCN2CCC(C3=CC=C(C=C3)Cl)(CC2)O)=O)CCC
Molecular Formula
C29H39ClFNO3
Molecular Weight
504.08
References & Citations
[1]Barbaraci C, et al. Haloperidol Metabolite II Valproate Ester (S) - (-) -MRJF22: Preliminary Studies as a Potential Multifunctional Agent Against Uveal Melanoma. J Med Chem. 2021;64 (18) :13622-13632.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog